Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × Lutetium-177 × Clear all

Sponsor

Conditions

Prostatic Neoplasms 1 Pheochromocytoma 1 Paraganglioma 1 Neoplasm Metastasis 1 Gastro-enteropancreatic neuroendocrine tumor 1

Interventions

blinatumomab 6 Rituximab 4 Cyclophosphamide 4 Tacrolimus 3 ponatinib 2 fludarabine 2 denileukin diftitox 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Cytarabine 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 Alemtuzumab 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibrutinib 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡